EU and US could reach trade deal this weekend - Reuters
Investing.com - Cardinal Health (NYSE:CAH) reported better-than-expected third-quarter earnings and raised its full-year guidance, driven by strong performance across all business segments.
The healthcare services company posted adjusted earnings per share of $2.35 for the third quarter of fiscal year 2025, surpassing analyst estimates of $2.17 by $0.18.
Revenue for the quarter came in at $54.9 billion, slightly below the consensus estimate of $55.32 billion.
While revenue was flat YoY, it increased 19% when excluding the impact of a previously announced customer contract expiration.
Cardinal Health’s non-GAAP operating earnings rose 21% to $807 million, with all five operating segments contributing to growth.
The company’s Pharmaceutical (TADAWUL:2070) and Specialty Solutions segment showed particularly strong performance, leading to an increased outlook for the division.
Based on the robust quarterly results, Cardinal Health raised and narrowed its fiscal 2025 guidance for non-GAAP diluted EPS to $8.05-$8.15, up from its previous range of $7.85-$8.00.
This new outlook is above the current analyst consensus of $7.96.
The company also provided an initial outlook for fiscal 2026, anticipating double-digit non-GAAP EPS growth despite evolving macroeconomic conditions.
Cardinal Health plans to discuss its expectations for fiscal 2026 and beyond at its upcoming Investor Day on June 12, 2025.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.